Sarcopenia Epidemiology Forecast to 2023: Focus on US, France, Germany, Italy, Spain, UK and Japan - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Sarcopenia - Epidemiology Forecast to 2023" report to their offering.

The prevalent cases of Sarcopenia in 7MM are expected to increase and reach up to 42,969,489 cases by the end of year 2023.

Sarcopenia - Epidemiology Forecast to 2023 report provides an overview of the epidemiology trends of Sarcopenia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes historical and forecasted epidemiological data for the prevalent cases of Sarcopenia from 2013-2023.

Sarcopenia is the progressive loss of skeletal muscle that comes with aging. Sarcopenia is multifactorial in cause. Most people begin to lose modest amounts of muscle mass after age 30, but the resulting loss of strength increases exponentially with age. Of the contributory factors relating to the development of sarcopenia inadequate protein intake, increased splanchnic extraction of amino acids, decreased muscular response to postprandial anabolic stimuli and vitamin D deficiency are directly related to nutrition.

Key Topics Covered:

1. Report Introduction

Sarcopenia: Overview

Pathophysiology

Symptoms

Diagnosis

Sarcopenia categories and stages

2. EWGSOP Conceptual Stages of Sarcopenia

Treatment

Challenges

Unmet Need

3. Epidemiology of Sarcopenia in 7MM

4. Epidemiology and Patient Population

5. Assumptions and Caveats

6. Prevalent Population of Sarcopenia in 7MM

United States

Europe

United Kingdom

France

Italy

Spain

Germany

Japan

For more information about this report visit http://www.researchandmarkets.com/research/tprqln/sarcopenia

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Asthma Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Asthma Drugs